Schering sales, earnings climb

Pharmaceutical firm Schering reported preliminary 2001 sales of $4.3 billion, up 10% over 2000 sales after adjusting for currency effects. The Berlin-based vendor had preliminary net income of $372 million, up 24% compared with 2000. Schering will publish its annual report on March 1.

By AuntMinnie.com staff writers
February 5, 2002

Related Reading

Schering buys rest of CIS bio, January 3, 2002

Schering gets approval for Resovist in Sweden, March 28, 2001

Schering gains Japanese rights to Epix’s MS-325, January 9, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 3617
Next Page